Place/Date: Vancouver, British Columbia, Canada - April 20th, 2021 at 11:00 am UTC · 4 min read
Contact: GCAC, Source: Global Cannabis Applications Corp.
Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced today that it has launched a Uniswap token  as part of a digital marketing campaign aimed at the one million decentralized finance user community ‘DeFi’ .
Company believes that the Uniswap community is an excellent target audience as this key demographic are consumers that have disposable income, are under 34 years old and increasingly drawn to the use of cannabis products . This multi-year marketing campaign aims to raise awareness of its products and its Efixii ‘QR codes’ by launching a Uniswap token on the Ethereum blockchain with the Company’s name, logo and website visible to all of the Uniswap community.
Company is publicly traded with audited financials and makes accurate revenue disclosures. GCAC’s Uniswap-inclusion marketing initiative is to commit to a marketing-spend of 1% of its quarterly sales revenue buying GCAC tokens on Uniswap every 3 months. Each Uniswap token-buy should lead to greater awareness of the Company’s products and drive potential new cannabis consumers to look for Efixii ‘QR codes’ on the products that they are purchasing on-line.
Brad Moore, CEO, stated:
“First and foremost, We – Are – Blockchain. So, I’m delighted to expand our marketing reach to fellow blockchain proponents. Cannabis consumers come in many forms and I am really excited to be marketing directly to the Uniswap DeFi community and raising awareness of cannabis efficacy and quality amongst this rather liquid demographic.”
Mega-cap companies like Tesla (TSLA) are diversifying their balance sheets by adding the Bitcoin cryptocurrency . GCAC is now adding an Ether cryptocurrency based “alternative asset” to its balance sheet by buying GCAC marketing tokens on Uniswap with 1% of its revenues. GCAC represents the next generation of companies embracing alternative assets and continues to innovate and seek ways to expand awareness of the benefits of cannabis efficacy and product transparency.
The Uniswap GCAC marketing token is built and operated by Abbey Technology “Abbey” and this latest marketing token has a unique set of features including:
GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world’s first end-to-end – from patient to regulator – medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.
Abbey, a Swiss company, specializes in developing, licensing and operating innovative blockchain technologies. The “Public-Company to Uniswap-Token” marketing platform was invented by Abbey alongside its Ethereum layer-2 high-throughput blockchain software-as-a-service. For information on Uniswap-token marketing campaigns for public companies visit the website.
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.